Breaking News Instant updates and real-time market news.

CVS

CVS Health

$79.12

(0.00%)

09:28
08/08/17
08/08
09:28
08/08/17
09:28

CVS Health says not waiting on tax reform to make investments in business

Says "encouraged" by recent tax discussions.

  • 08

    Aug

  • 21

    Sep

  • 22

    Sep

CVS CVS Health
$79.12

(0.00%)

06/27/17
LEER
06/27/17
NO CHANGE
Target $90
LEER
Outperform
CVS gained largest PBM share in 2017 selling season, says Leerink
Leerink analyst David Larsen says his firm's recently published Pharmacy Benefit Manager survey shows that CVS Health is the largest share gainer in the 2017 selling season. The company is poised to win incremental PBM and Specialty Pharmacy share, while the Optum and Cigna deals will start to benefit retail volumes in the near-term, Larsen tells investors in a research note. He keeps an Outperform rating on CVS shares with a $90 price target.
06/27/17
NEED
06/27/17
INITIATION
NEED
Hold
CVS Health initiated with a Hold at Needham
Needham analyst Kevin Caliendo initiated CVS Health with a Hold.
06/28/17
06/28/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Altaba (AABA) initiated with an Overweight at JPMorgan. 2. Aetna (AET) and Humana (HUM) were initiated with a Buy at Citi. The firm also added Aetna to its Focus List. 3. CVS Health (CVS) and Walgreens Boots Alliance (WBA) were initiated with a Hold at Needham. 4. Oaktree Capital (OAK) initiated with a Hold at Jefferies. 5. General Motors (GM) resumed with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/28/17
WELS
07/28/17
NO CHANGE
Target $9
WELS
Underperform
Insurers are dropping Valeant's top products, says Wells Fargo
United Healthcare's (UNH) formulary is no longer covering Valeant Pharmaceuticals' (VRX) number three branded drug Solodyn and will also now exclude Retin-A brand, its number four branded drug, Wells Fargo analyst David Maris tells investors in a research note. The analyst estimates the two drugs represented approximately $214M of Valeant's sales in 2016. Maris also points out that Glumetza, Valeant's number eight branded drug, and Relistor were removed in July from CVS/Caremark's (CVS) formulary. These two drugs had approximately $119M in 2016 revenues. Maris notes his counterpart Peter Costa estimates that United Healthcare covers approximately 17% of the U.S. and CVS covers approximately 33%. Express Scripts (ESRX) is releasing its 2018 national formulary next week, Costa adds. Maris keeps an Underperform rating on shares of Valeant with a $9 price target. The stock in premarket trading is down 33c, or 2%, to $16.80.

TODAY'S FREE FLY STORIES

SPPI

Spectrum

$16.34

-5.03 (-23.54%)

15:55
09/24/18
09/24
15:55
09/24/18
15:55
Conference/Events
Spectrum to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

ASPS

Altisource

$34.40

0.3 (0.88%)

15:55
09/24/18
09/24
15:55
09/24/18
15:55
Conference/Events
Altisource to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

VSTM

Verastem

$8.89

0.22 (2.54%)

15:51
09/24/18
09/24
15:51
09/24/18
15:51
Hot Stocks
Verastem receives FDA approval of Copiktra capsules »

Verastem announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

JBL

Jabil

$30.11

0.25 (0.84%)

15:50
09/24/18
09/24
15:50
09/24/18
15:50
Options
Jabil options volume is 12X daily average ahead of earnings »

Jabil options volume is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 09

    Oct

  • 13

    Nov

TDOC

Teladoc

$78.35

0.25 (0.32%)

15:42
09/24/18
09/24
15:42
09/24/18
15:42
Conference/Events
Teladoc to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

CWH

Camping World

$20.48

-1.59 (-7.20%)

15:40
09/24/18
09/24
15:40
09/24/18
15:40
Options
Closing call option block in Camping World as shares retreat »

Closing call option block…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

SEAS

SeaWorld

$29.91

-0.19 (-0.63%)

15:35
09/24/18
09/24
15:35
09/24/18
15:35
Options
SeaWorld put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$95.05

-0.8 (-0.83%)

, IBM

IBM

$149.98

-1.31 (-0.87%)

15:31
09/24/18
09/24
15:31
09/24/18
15:31
Periodicals
Walmart requires lettuce, spinach suppliers to join blockchain, WSJ reports »

In a letter to suppliers,…

WMT

Walmart

$95.05

-0.8 (-0.83%)

IBM

IBM

$149.98

-1.31 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 22

    Oct

  • 28

    Oct

  • 15

    Nov

  • 03

    Mar

FL

Foot Locker

$47.57

-0.71 (-1.47%)

15:25
09/24/18
09/24
15:25
09/24/18
15:25
Options
Foot Locker call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

CDNA

CareDx

$26.73

0.75 (2.89%)

, NTRA

Natera

$23.95

-0.23 (-0.95%)

15:25
09/24/18
09/24
15:25
09/24/18
15:25
Conference/Events
Piper Jaffray biotech analysts to hold an analyst/industry conference call »

Biotech Analysts discuss…

CDNA

CareDx

$26.73

0.75 (2.89%)

NTRA

Natera

$23.95

-0.23 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 01

    Oct

  • 15

    Nov

  • 27

    Nov

SBUX

Starbucks

$56.91

-0.49 (-0.85%)

15:24
09/24/18
09/24
15:24
09/24/18
15:24
Periodicals
Starbucks plans 'significant changes' to company structure, Bloomberg says »

Starbucks is planning an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

TMK

Torchmark

$88.45

-0.51 (-0.57%)

15:17
09/24/18
09/24
15:17
09/24/18
15:17
Syndicate
Breaking Syndicate news story on Torchmark »

Torchmark files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
09/24/18
09/24
15:17
09/24/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
09/24/18
09/24
15:16
09/24/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.35

-0.6 (-1.09%)

15:10
09/24/18
09/24
15:10
09/24/18
15:10
Options
Wells Fargo with a notable option spread as shares slip »

Wells Fargo with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Oct

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

BSX

Boston Scientific

$38.37

0.61 (1.62%)

15:05
09/24/18
09/24
15:05
09/24/18
15:05
Options
Boston Scientific call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 09

    Oct

SWCH

Switch

$10.83

-0.23 (-2.08%)

, INTC

Intel

$46.92

0.28 (0.60%)

15:04
09/24/18
09/24
15:04
09/24/18
15:04
Hot Stocks
Intel Capital sells about 1.728M shares of Switch »

According to a regulatory…

SWCH

Switch

$10.83

-0.23 (-2.08%)

INTC

Intel

$46.92

0.28 (0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 22

    Oct

MTNB

Matinas BioPharma

$0.55

0.1392 (33.98%)

, AMRN

Amarin

$11.62

8.62 (287.33%)

15:03
09/24/18
09/24
15:03
09/24/18
15:03
Recommendations
Matinas BioPharma, Amarin analyst commentary  »

Amarin's Vascepa…

MTNB

Matinas BioPharma

$0.55

0.1392 (33.98%)

AMRN

Amarin

$11.62

8.62 (287.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

15:00
09/24/18
09/24
15:00
09/24/18
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

KOS

Kosmos

$9.45

-0.06 (-0.63%)

14:58
09/24/18
09/24
14:58
09/24/18
14:58
Hot Stocks
Breaking Hot Stocks news story on Kosmos »

First Reserve GP XIII…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$10.76

-0.3 (-2.71%)

14:58
09/24/18
09/24
14:58
09/24/18
14:58
Conference/Events
Switch management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

CGC

Canopy Growth

$52.68

2.92 (5.87%)

, CVSI

CV Sciences

$0.00

(0.00%)

14:55
09/24/18
09/24
14:55
09/24/18
14:55
Hot Stocks
NY Governor signs bill adding pain management as condition for medical marijuana »

New York Governor Andrew…

CGC

Canopy Growth

$52.68

2.92 (5.87%)

CVSI

CV Sciences

$0.00

(0.00%)

ACBFF

Aurora Cannabis

$0.00

(0.00%)

CRON

Cronos Group

$11.80

-0.71 (-5.68%)

TLRY

Tilray

$105.00

-18.155 (-14.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

SBUX

Starbucks

$56.88

-0.52 (-0.91%)

14:50
09/24/18
09/24
14:50
09/24/18
14:50
Periodicals
Starbucks plans 'significant changes' to company structure, Bloomberg says »

Starbucks'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

RRGB

Red Robin

$38.65

-0.55 (-1.40%)

14:50
09/24/18
09/24
14:50
09/24/18
14:50
Conference/Events
Red Robin management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ASNA

Ascena Retail

$3.94

-0.29 (-6.86%)

14:49
09/24/18
09/24
14:49
09/24/18
14:49
Options
Ascena Retail options imply 24.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.